These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 900834)

  • 1. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 4. The electrophysiology of Norpace (Part II).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract]   [Full Text] [Related]  

  • 5. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 6. The electrophysiology of Norpace (Part I).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Electrophysiological effects of disopyramide on the specialized cardiac conduction system in man (author's transl)].
    Hombach V; Hespe I; Gil-Sanchez D; Freyland MD; Behrenbeck DW; Krüger H; Tauchert M; Hilger HH
    Z Kardiol; 1978 Aug; 67(8):527-33. PubMed ID: 695804
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 9. [Electrophysiological interrelations of disopyramide with atropine].
    González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
    Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 13. Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings].
    Marrott PK; Ruttley MS; Winterbott JT; Muir JR
    Br J Clin Pharmacol; 1975 Aug; 2(4):373P. PubMed ID: 1234005
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of disopyramide on electrophysiological and mechanical properties of the heart.
    Yeh BK; Sung PK; Scherlag BJ
    J Pharm Sci; 1973 Dec; 62(12):1924-9. PubMed ID: 4762159
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the acute electrophysiological and cardiovascular action of disopyramide in man.
    Marrott PK; Ruttley MS; Winterbottam JT; Muir JR
    Eur J Cardiol; 1976 Sep; 4(3):303-12. PubMed ID: 964279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of disopyramide on the human heart: an electrophysiological study.
    Spurrell RA
    J Int Med Res; 1976; 4(1 Suppl):31-6. PubMed ID: 1026526
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of atropine, propafenon and disopyramide on "sino-atrial conduction time" in man].
    Breithardt G; Seipel L; Both A; Loogen F
    Verh Dtsch Ges Inn Med; 1975; 81():1634-7. PubMed ID: 1227042
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.